Accretion Pharmaceuticals SME IPO Subscription
ListedUpdated 21 May 2025, 9:15 AM IST· NSE SME
Accretion Pharmaceuticals SME IPO subscription closed on 16 May 2025 at 7.67x overall by shares. QIB demand came in at 12.14x, NII at 4.28x, and retail at 10.44x. See Retail, SHNI, and BHNI allotment chances in the…
Accretion Pharmaceuticals SME IPO subscription closed on 16 May 2025 at 7.67x overall by shares. QIB demand came in at 12.14x, NII at 4.28x, and retail at 10.44x. See Retail, SHNI, and BHNI allotment chances in the table below.
Show moreShow less
Allotment date is 19 May 2025. Listing date on NSE and BSE is 21 May 2025.
Accretion Pharmaceuticals SME IPO Day-wise Subscription
Daily QIB, NII, Retail, and overall subscription as bids come in
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 14 May 2025 | 0.00x | 0.51x | 1.86x | 1.12x |
| Day 2 - 15 May 2025 | 0.75x | 0.92x | 4.01x | 2.37x |
| Day 3 - 16 May 2025 | 12.14x | 4.28x | 10.44x | 7.62x |
Accretion Pharmaceuticals SME IPO Allotment Chances
Retail, SHNI, and BHNI chances based on application subscription
Accretion Pharmaceuticals SME IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
| Category | Subscription (Apps) | Allotment Chances |
|---|---|---|
| Retail (IND) | 10.44x (shares) | Updating soon |
Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.
Check the Accretion Pharmaceuticals SME IPO Allotment Status page from 19 May 2025 for your result.
Accretion Pharmaceuticals SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 101.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 1.43 Cr | Rs 17.37 Cr | 12.14x |
| NII | Rs 12.35 Cr | Rs 52.81 Cr | 4.28x |
| IND | Rs 12.35 Cr | Rs 128.94 Cr | 10.44x |
| Total | Rs 26.13 Cr | Rs 199.12 Cr | 7.62x |
What Do These Subscription Numbers Mean?
7.67x overall by shares means bids covered about 8 times the shares on offer. Allotment chances depend on applications in each category.
QIB at 12.14x by shares shows institutional demand from mutual funds, FIIs, and banks.
NII covers bids above Rs 2 lakh (4.28x by shares). SHNI and BHNI allotment is by lottery.
Retail at 10.44x by shares. Exact lottery chances need application data.
Accretion Pharmaceuticals SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| Allotment Date | 19 May 2025 |
| Refund Initiation | 20 May 2025 |
| Share Credit to Demat | 20 May 2025 |
| Listing Date | 21 May 2025 |
| Minimum Investment | Rs 2,42,400.00 |
| Lot Size | 1200 shares |
About Accretion Pharmaceuticals SME
No company information available
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
IND - Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
Accretion Pharmaceuticals SME IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Accretion Pharmaceuticals SME Details
Issue size, price, financials, and company info
Accretion Pharmaceuticals SME GMP
Live grey market premium and listing estimate
Accretion Pharmaceuticals SME Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Accretion Pharmaceuticals SME Allotment
Allotment date, chances, and check by PAN
Accretion Pharmaceuticals SME Review
SWOT, strengths, risks, and IPO review
Accretion Pharmaceuticals SME FAQ
Common questions on dates, GMP, and allotment
Accretion Pharmaceuticals SME Registrar
Registrar website and how to check allotment
Accretion Pharmaceuticals SME Timeline
Open, close, allotment, and listing dates
Accretion Pharmaceuticals SME News
Updates, blogs, and latest IPO news
Accretion Pharmaceuticals SME IPO Subscription FAQs
What is Accretion Pharmaceuticals SME IPO subscription status today?
Accretion Pharmaceuticals SME IPO subscription closed on 16 May 2025 with overall subscription of 7.67x (by shares) as of 27 August 2026, 4:32 AM IST. QIB 12.14x, NII 4.28x, IND 10.44x.
What is the overall subscription of Accretion Pharmaceuticals SME IPO?
Accretion Pharmaceuticals SME IPO is subscribed 7.67x overall by shares at close on 16 May 2025. QIB 12.14x, NII 4.28x, and IND 10.44x.
What is Accretion Pharmaceuticals SME IPO QIB subscription?
Accretion Pharmaceuticals SME IPO QIB (Qualified Institutional Buyers) subscription is 12.14x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Accretion Pharmaceuticals SME IPO IND subscription?
Accretion Pharmaceuticals SME IPO IND subscription is 10.44x by shares. Retail bids are up to Rs 2 lakh per PAN.
What is Accretion Pharmaceuticals SME IPO NII, SHNI, and BHNI subscription?
Accretion Pharmaceuticals SME IPO NII subscription is 4.28x by shares. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) and BHNI (above Rs 10L).
What are Accretion Pharmaceuticals SME IPO retail allotment chances?
Accretion Pharmaceuticals SME IPO retail share subscription is 10.44x. Application data is needed for exact lottery chances.
What are Accretion Pharmaceuticals SME IPO SHNI allotment chances?
Accretion Pharmaceuticals SME IPO SHNI allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.
What are Accretion Pharmaceuticals SME IPO BHNI allotment chances?
Accretion Pharmaceuticals SME IPO BHNI allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.
When is Accretion Pharmaceuticals SME IPO allotment date?
Accretion Pharmaceuticals SME IPO allotment date is 19 May 2025. Check Accretion Pharmaceuticals SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Accretion Pharmaceuticals SME IPO subscription close?
Accretion Pharmaceuticals SME IPO subscription closed on 16 May 2025. No new applications are accepted after the close.
What is Accretion Pharmaceuticals SME IPO GMP today?
GMP for Accretion Pharmaceuticals SME IPO is not available yet. Track Accretion Pharmaceuticals SME IPO GMP Today on IPOwiz once grey market activity starts.
What is Accretion Pharmaceuticals SME IPO issue price and lot size?
Accretion Pharmaceuticals SME IPO issue price is ₹101 per share. Lot size is 1200 shares. Minimum investment is ₹2,42,400 per lot (minimum 2 lots for SME). Issue size: ₹29.75 Cr.
When is Accretion Pharmaceuticals SME IPO listing date?
Accretion Pharmaceuticals SME IPO listing date is 21 May 2025 on NSE and BSE. Allotment is on 19 May 2025.
How does subscription affect Accretion Pharmaceuticals SME IPO allotment?
In Accretion Pharmaceuticals SME IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 7.67x overall, competition is moderate.
For allotment results from 19 May 2025, visit the Accretion Pharmaceuticals SME IPO Allotment Status page. For listing day updates on 21 May 2025, download the IPOwiz App.
Sources
We match Accretion Pharmaceuticals SME IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.